BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 14715822)

  • 41. A 10-year follow-up of bone mineral density in HIV-infected youths receiving tenofovir disoproxil fumarate.
    Giacomet V; Maruca K; Ambrosi A; Zuccotti GV; Mora S
    Int J Antimicrob Agents; 2017 Sep; 50(3):365-370. PubMed ID: 28689877
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of puberty on the relationship between bone markers of turnover and bone mineral density in Turner's syndrome.
    Gallicchio CT; Figueiredo-Alves ST; Prendin Tórtora R; Mendonça LM; Farias ML; Guimarães MM
    Horm Res; 2004; 61(4):193-9. PubMed ID: 14752210
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Decreased serum bone specific alkaline phosphatase and increased urinary N-terminal telopeptide of type I collagen as prognostic markers for bone mineral density loss in HIV patients on cART.
    Koga I; Seo K; Yoshino Y; Kitazawa T; Kurahashi I; Ota Y
    J Infect Chemother; 2016 Aug; 22(8):543-7. PubMed ID: 27346381
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Impaired development of bone mineral density during chemotherapy: a prospective analysis of 46 children newly diagnosed with cancer.
    Arikoski P; Komulainen J; Riikonen P; Parviainen M; Jurvelin JS; Voutilainen R; Kröger H
    J Bone Miner Res; 1999 Dec; 14(12):2002-9. PubMed ID: 10620058
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Body mass index (BMI) and parameters of bone formation and resorption in postmenopausal women.
    Papakitsou EF; Margioris AN; Dretakis KE; Trovas G; Zoras U; Lyritis G; Dretakis EK; Stergiopoulos K
    Maturitas; 2004 Mar; 47(3):185-93. PubMed ID: 15036488
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of low-dose alendronate treatment on bone mineral density and bone turnover markers in Chinese postmenopausal women with osteopenia and osteoporosis.
    Li M; Zhang ZL; Liao EY; Chen DC; Liu J; Tao TZ; Wu W; Xia WB; Lu YJ; Sheng ZF; Lu CY; Meng GL; Xu L; Zhang WJ; Hu YY; Xu L
    Menopause; 2013 Jan; 20(1):72-8. PubMed ID: 22968256
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Secondary osteoporosis in liver transplant recipients: a longitudinal study in patients with and without cholestatic liver disease.
    Bjøro K; Brandsaeter B; Wiencke K; Bjøro T; Godang K; Bollerslev J; Schrumpf E
    Scand J Gastroenterol; 2003 Mar; 38(3):320-7. PubMed ID: 12737449
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of intravenous zoledronate on bone turnover and bone density persist for at least five years in HIV-infected men.
    Bolland MJ; Grey A; Horne AM; Briggs SE; Thomas MG; Ellis-Pegler RB; Gamble GD; Reid IR
    J Clin Endocrinol Metab; 2012 Jun; 97(6):1922-8. PubMed ID: 22419728
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Correlation between salivary and serum markers of bone turnover in osteopenic rats.
    Pellegrini GG; Gonzales CM; Somoza JC; Friedman SM; Zeni SN
    J Periodontol; 2008 Jan; 79(1):158-65. PubMed ID: 18166106
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Changes in bone mineral density, body composition, and lipid metabolism during growth hormone (GH) treatment in children with GH deficiency.
    Boot AM; Engels MA; Boerma GJ; Krenning EP; De Muinck Keizer-Schrama SM
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2423-8. PubMed ID: 9253311
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Age-related changes of serum bone alkaline phosphatase and cross-linked C-telopeptides of type I collagen and the relationship with bone mineral density in Chinese women.
    Shan PF; Wu XP; Zhang H; Luo XH; Cao XZ; Xie H; Liu SP; Pi YZ; Fang TY; Liu H; Chen ZH; Zhong N; Liao EY
    Clin Chim Acta; 2006 Apr; 366(1-2):233-8. PubMed ID: 16330011
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Early changes in biochemical markers of bone formation predict BMD response to teriparatide in postmenopausal women with osteoporosis.
    Chen P; Satterwhite JH; Licata AA; Lewiecki EM; Sipos AA; Misurski DM; Wagman RB
    J Bone Miner Res; 2005 Jun; 20(6):962-70. PubMed ID: 15883636
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Osteopenia in HIV-infected women prior to highly active antiretroviral therapy.
    Teichmann J; Stephan E; Lange U; Discher T; Friese G; Lohmeyer J; Stracke H; Bretzel RG
    J Infect; 2003 May; 46(4):221-7. PubMed ID: 12799147
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Longitudinal monitoring of bone mass accumulation in healthy adolescents: evidence for a marked reduction after 16 years of age at the levels of lumbar spine and femoral neck in female subjects.
    Theintz G; Buchs B; Rizzoli R; Slosman D; Clavien H; Sizonenko PC; Bonjour JP
    J Clin Endocrinol Metab; 1992 Oct; 75(4):1060-5. PubMed ID: 1400871
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Effect of physical activity on bone turnover in young boys].
    Kalaï E; Bahlous A; Nbigh A; Sahli H; Sellami S; Abdelmoula J
    Ann Biol Clin (Paris); 2007; 65(5):519-24. PubMed ID: 17913670
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Stable bone density in HAART-treated individuals with HIV: a meta-analysis.
    Bolland MJ; Wang TK; Grey A; Gamble GD; Reid IR
    J Clin Endocrinol Metab; 2011 Sep; 96(9):2721-31. PubMed ID: 21715534
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Longitudinal evolution of bone mineral density and bone markers in human immunodeficiency virus-infected individuals.
    Mondy K; Yarasheski K; Powderly WG; Whyte M; Claxton S; DeMarco D; Hoffmann M; Tebas P
    Clin Infect Dis; 2003 Feb; 36(4):482-90. PubMed ID: 12567307
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Decreased bone mineral density in HIV-infected patients is independent of antiretroviral therapy.
    Bruera D; Luna N; David DO; Bergoglio LM; Zamudio J
    AIDS; 2003 Sep; 17(13):1917-23. PubMed ID: 12960824
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Assessment of the bone status of Nigerian children and adolescents with sickle cell disease using calcaneal ultrasound and serum markers of bone metabolism.
    VanderJagt DJ; Bonnett C; Okolo SN; Glew RH
    Calcif Tissue Int; 2002 Aug; 71(2):133-40. PubMed ID: 12200647
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Reduced bone mineral density among HIV-infected patients in Taiwan: prevalence and associated factors.
    Tsai MS; Hung CC; Liu WC; Chen KL; Chen MY; Hsieh SM; Sheng WH; Sun HY; Shih TT
    J Microbiol Immunol Infect; 2014 Apr; 47(2):109-15. PubMed ID: 23073318
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.